Stockreport

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the de [Read more]